TP53 and glioblastoma: Furthermore CENPF, ASPM and CASC5 are known to contribute to phenotypic variation in glioblastoma neoplastic cells (Wang et al., 2022) and they were among the eight p53-DREAM target genes most affected by BRD8 levels (Fig. 4B; Table S37).